After having studied mathematics as well as business mathematics in Milwaukee and Ulm, respectively, Frank received his Ph.D. in statistics from Ulm University in 2007. He joined the biostatistics group at Boehringer-Ingelheim
initially acting as a project statistician for several years working in oncology, immunology and biosimilars. Currently, he is acting as an expert methodology statistician. In this role, Frank considers methodological questions regarding adaptive designs, statistical decision making, dose finding
and Bayesian data enrichment thereby supporting several projects across different therapeutic areas.
He has published several articles and book chapters. He is providing lectures on topics like adaptive designs, dose finding and Bayesian statistics at Ulm University and Shanghai Jiao Tong University. Frank has served as a member of the scientific board of the European St